120 related articles for article (PubMed ID: 22438047)
1. Non-invasive quantification of tumor vascular architecture during docetaxel-chemotherapy.
Mahéo K; Chevalier S; Vibet S; Bougnoux P; Richard S; Serrière S; Bleuzen A; Tranquart F; Goupille C
Breast Cancer Res Treat; 2012 Aug; 134(3):1013-25. PubMed ID: 22438047
[TBL] [Abstract][Full Text] [Related]
2. High pathologic complete response in HER 2-positive locally advanced breast cancer after primary systemic chemotherapy with weekly docetaxel and epirubicin.
Chen SC; Chang HK; Lin YC; Hsueh S; Cheung YC; Leung WM; Tsai CS; Lo YF; Tsai HP; Shen SC; Chen MF
Jpn J Clin Oncol; 2008 Feb; 38(2):99-105. PubMed ID: 18270380
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.
Iwata H; Sato N; Masuda N; Nakamura S; Yamamoto N; Kuroi K; Kurosumi M; Tsuda H; Akiyama F; Ohashi Y; Toi M
Jpn J Clin Oncol; 2011 Jul; 41(7):867-75. PubMed ID: 21719750
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced MR imaging in a phase Ⅱ study on neoadjuvant chemotherapy combining Rh-endostatin with docetaxel and epirubicin for locally advanced breast cancer.
Jia Q; Xu J; Jiang W; Zheng M; Wei M; Chen J; Wang L; Huan Y
Int J Med Sci; 2013; 10(2):110-8. PubMed ID: 23329881
[TBL] [Abstract][Full Text] [Related]
5. Ultrasonographic, thermographic and histologic evaluation of MNU-induced mammary tumors in female Sprague-Dawley rats.
Faustino-Rocha AI; Silva A; Gabriel J; Teixeira-Guedes CI; Lopes C; Gil da Costa R; Gama A; Ferreira R; Oliveira PA; Ginja M
Biomed Pharmacother; 2013 Oct; 67(8):771-6. PubMed ID: 23906759
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice.
Huang X; Bennett M; Thorpe PE
Cancer Res; 2005 May; 65(10):4408-16. PubMed ID: 15899833
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study.
von Minckwitz G; Rezai M; Loibl S; Fasching PA; Huober J; Tesch H; Bauerfeind I; Hilfrich J; Eidtmann H; Gerber B; Hanusch C; Kühn T; du Bois A; Blohmer JU; Thomssen C; Dan Costa S; Jackisch C; Kaufmann M; Mehta K; Untch M
J Clin Oncol; 2010 Apr; 28(12):2015-23. PubMed ID: 20308671
[TBL] [Abstract][Full Text] [Related]
8. Study on breast cancer animal model of tumor-micro vessel variation before and after the chemotherapy by contrast enhanced ultrasound quantitative analysis.
Zhou SC; Le J; Fan YW; Chen M; Chang C
Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1407-13. PubMed ID: 27592472
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy.
Saracco A; Szabó BK; Tánczos E; Bergh J; Hatschek T
Acta Radiol; 2017 Apr; 58(4):394-402. PubMed ID: 27461224
[TBL] [Abstract][Full Text] [Related]
10. Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy.
Li SP; Taylor NJ; Makris A; Ah-See ML; Beresford MJ; Stirling JJ; d'Arcy JA; Collins DJ; Padhani AR
Radiology; 2010 Dec; 257(3):643-52. PubMed ID: 20858850
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound imaging of breast tumor perfusion and neovascular morphology.
Hoyt K; Umphrey H; Lockhart M; Robbin M; Forero-Torres A
Ultrasound Med Biol; 2015 Sep; 41(9):2292-302. PubMed ID: 26116159
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of neoadjuvant chemotherapy with docetaxel followed by epirubicin in stage II/III breast cancer.
Ramaswamy B; Povoski SP; Rhoades C; Allen J; Hauger M; Young D; Burak W; Farrar W; Yee L; Kendra K; Somasundaram S; Orlowski RZ; Shapiro CL
Breast Cancer Res Treat; 2005 Sep; 93(1):67-74. PubMed ID: 16184461
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.
von Minckwitz G; Kümmel S; Vogel P; Hanusch C; Eidtmann H; Hilfrich J; Gerber B; Huober J; Costa SD; Jackisch C; Loibl S; Mehta K; Kaufmann M;
J Natl Cancer Inst; 2008 Apr; 100(8):542-51. PubMed ID: 18398097
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of Doppler ultrasound in evaluation of breast tumors].
Grischke EM; von Fournier D; Sohn C; Wallwiener D; Bastert G
Zentralbl Gynakol; 1996; 118(10):553-9. PubMed ID: 8999709
[TBL] [Abstract][Full Text] [Related]
15. Potential application value of contrast-enhanced ultrasound in neoadjuvant chemotherapy of breast cancer.
Cao X; Xue J; Zhao B
Ultrasound Med Biol; 2012 Dec; 38(12):2065-71. PubMed ID: 23062366
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.
Francis P; Crown J; Di Leo A; Buyse M; Balil A; Andersson M; Nordenskjöld B; Lang I; Jakesz R; Vorobiof D; Gutiérrez J; van Hazel G; Dolci S; Jamin S; Bendahmane B; Gelber RD; Goldhirsch A; Castiglione-Gertsch M; Piccart-Gebhart M;
J Natl Cancer Inst; 2008 Jan; 100(2):121-33. PubMed ID: 18182617
[TBL] [Abstract][Full Text] [Related]
17. Changes in tumor vascularization after irradiation, anthracyclin, or antiangiogenic treatment in nitrosomethyl ureas-induced rat mammary tumors.
Denis F; Colas S; Chami L; Louisot P; Le Floch O; Tranquart F; Bougnoux P
Clin Cancer Res; 2003 Oct; 9(12):4546-52. PubMed ID: 14555529
[TBL] [Abstract][Full Text] [Related]
18. Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastases.
Merz M; Komljenovic D; Semmler W; Bäuerle T
Invest Radiol; 2012 Jul; 47(7):422-9. PubMed ID: 22659593
[TBL] [Abstract][Full Text] [Related]
19. EPA and DHA Fatty Acids Induce a Remodeling of Tumor Vasculature and Potentiate Docetaxel Activity.
Goupille C; Vibet S; Frank PG; Mahéo K
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32674321
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.
Naume B; Synnestvedt M; Falk RS; Wiedswang G; Weyde K; Risberg T; Kersten C; Mjaaland I; Vindi L; Sommer HH; Sætersdal AB; Rypdal MC; Bendigtsen Schirmer C; Wist EA; Borgen E
J Clin Oncol; 2014 Dec; 32(34):3848-57. PubMed ID: 25366688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
